Which has higher valuation and earnings, ALGN or NVST?

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Align Technology $4.03B 3.21 $410.35M $5.96 30.30 Envista $2.72B 1.57 $47M $0.41 63.97

Does the media prefer ALGN or NVST?

In the previous week, Align Technology had 4 more articles in the media than Envista. MarketBeat recorded 10 mentions for Align Technology and 6 mentions for Envista. Align Technology's average media sentiment score of 0.96 beat Envista's score of 0.65 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 3 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer XRAY or NVST?

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than Envista. MarketBeat recorded 8 mentions for DENTSPLY SIRONA and 6 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 1.16 beat Envista's score of 0.65 indicating that DENTSPLY SIRONA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment DENTSPLY SIRONA 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is BRBR or NVST more profitable?

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity. Company Net Margins Return on Equity Return on Assets BellRing Brands 6.78% -44.06% 19.42% Envista 2.41% 7.11% 3.91%

Does the media prefer BRBR or NVST?

In the previous week, BellRing Brands had 6 more articles in the media than Envista. MarketBeat recorded 12 mentions for BellRing Brands and 6 mentions for Envista. Envista's average media sentiment score of 0.65 beat BellRing Brands' score of 0.37 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BellRing Brands 1 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, NVST or ZBH?

Zimmer Biomet has higher revenue and earnings than Envista. Zimmer Biomet is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Envista $2.72B 1.57 $47M $0.41 63.97 Zimmer Biomet $8.23B 2.21 $705.20M $3.85 24.44

Is NVST or ZBH more profitable?

Zimmer Biomet has a net margin of 9.05% compared to Envista's net margin of 2.41%. Zimmer Biomet's return on equity of 13.24% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Envista 2.41% 7.11% 3.91% Zimmer Biomet 9.05% 13.24% 7.28%

Does the media refer more to NVST or ZBH?

In the previous week, Zimmer Biomet had 5 more articles in the media than Envista. MarketBeat recorded 11 mentions for Zimmer Biomet and 6 mentions for Envista. Zimmer Biomet's average media sentiment score of 1.16 beat Envista's score of 0.65 indicating that Zimmer Biomet is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Zimmer Biomet 5 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, SOLV or NVST?

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Solventum $8.33B 1.61 $1.56B $8.16 9.50 Envista $2.72B 1.57 $47M $0.41 63.97

Is SOLV or NVST more profitable?

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity. Company Net Margins Return on Equity Return on Assets Solventum 17.33% 23.51% 7.63% Envista 2.41% 7.11% 3.91%

Does the media favor SOLV or NVST?

In the previous week, Solventum had 3 more articles in the media than Envista. MarketBeat recorded 9 mentions for Solventum and 6 mentions for Envista. Solventum's average media sentiment score of 1.32 beat Envista's score of 0.65 indicating that Solventum is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Solventum 5 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 1 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Envista (NVST) Competitors

$26.23 +0.32 (+1.23%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$26.23 +0.01 (+0.02%)

As of 07/13/2026 06:25 PM Eastern

Compare

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

Should you buy Envista stock or one of its competitors? MarketBeat compares Envista with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envista include Align Technology (ALGN), DENTSPLY SIRONA (XRAY), BellRing Brands (BRBR), Zimmer Biomet (ZBH), and Solventum (SOLV).

How does Envista compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Envista (NYSE:NVST) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

88.4% of Align Technology shares are held by institutional investors. 0.8% of Align Technology shares are held by insiders. Comparatively, 1.0% of Envista shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Align Technology has a beta of 1.67, indicating that its stock price is 67% more volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its stock price is 14% less volatile than the broader market.

Align Technology has a net margin of 10.50% compared to Envista's net margin of 2.41%. Align Technology's return on equity of 15.82% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	10.50%	15.82%	10.17%
Envista	2.41%	7.11%	3.91%

Align Technology has higher revenue and earnings than Envista. Align Technology is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.03B	3.21	$410.35M	$5.96	30.30
Envista	$2.72B	1.57	$47M	$0.41	63.97

Align Technology currently has a consensus target price of $206.07, suggesting a potential upside of 14.11%. Envista has a consensus target price of $28.54, suggesting a potential upside of 8.81%. Given Align Technology's stronger consensus rating and higher possible upside, equities analysts plainly believe Align Technology is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	5 Hold rating(s)	8 Buy rating(s)	2 Strong Buy rating(s)	2.80
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, Align Technology had 4 more articles in the media than Envista. MarketBeat recorded 10 mentions for Align Technology and 6 mentions for Envista. Align Technology's average media sentiment score of 0.96 beat Envista's score of 0.65 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	3 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Align Technology beats Envista on 15 of the 17 factors compared between the two stocks.

How does Envista compare to DENTSPLY SIRONA?

DENTSPLY SIRONA (NASDAQ:XRAY) and Envista (NYSE:NVST) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, valuation and profitability.

Envista has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
DENTSPLY SIRONA	$3.68B	0.70	-$598M	-$3.15	N/A
Envista	$2.72B	1.57	$47M	$0.41	63.97

95.7% of DENTSPLY SIRONA shares are held by institutional investors. 0.5% of DENTSPLY SIRONA shares are held by company insiders. Comparatively, 1.0% of Envista shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

In the previous week, DENTSPLY SIRONA had 2 more articles in the media than Envista. MarketBeat recorded 8 mentions for DENTSPLY SIRONA and 6 mentions for Envista. DENTSPLY SIRONA's average media sentiment score of 1.16 beat Envista's score of 0.65 indicating that DENTSPLY SIRONA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
DENTSPLY SIRONA	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a net margin of 2.41% compared to DENTSPLY SIRONA's net margin of -17.06%. DENTSPLY SIRONA's return on equity of 18.83% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
DENTSPLY SIRONA	-17.06%	18.83%	5.13%
Envista	2.41%	7.11%	3.91%

DENTSPLY SIRONA currently has a consensus target price of $13.42, suggesting a potential upside of 4.98%. Envista has a consensus target price of $28.54, suggesting a potential upside of 8.81%. Given Envista's stronger consensus rating and higher probable upside, analysts plainly believe Envista is more favorable than DENTSPLY SIRONA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
DENTSPLY SIRONA	3 Sell rating(s)	9 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

DENTSPLY SIRONA has a beta of 0.89, indicating that its share price is 11% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, indicating that its share price is 14% less volatile than the broader market.

Summary

Envista beats DENTSPLY SIRONA on 9 of the 16 factors compared between the two stocks.

How does Envista compare to BellRing Brands?

BellRing Brands (NYSE:BRBR) and Envista (NYSE:NVST) are related companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

BellRing Brands has a net margin of 6.78% compared to Envista's net margin of 2.41%. Envista's return on equity of 7.11% beat BellRing Brands' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
BellRing Brands	6.78%	-44.06%	19.42%
Envista	2.41%	7.11%	3.91%

BellRing Brands has higher earnings, but lower revenue than Envista. BellRing Brands is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BellRing Brands	$2.32B	0.64	$216.20M	$1.29	9.89
Envista	$2.72B	1.57	$47M	$0.41	63.97

In the previous week, BellRing Brands had 6 more articles in the media than Envista. MarketBeat recorded 12 mentions for BellRing Brands and 6 mentions for Envista. Envista's average media sentiment score of 0.65 beat BellRing Brands' score of 0.37 indicating that Envista is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
BellRing Brands	1 Very Positive mention(s)	0 Positive mention(s)	6 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

BellRing Brands has a beta of 0.45, suggesting that its stock price is 55% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

BellRing Brands presently has a consensus price target of $20.47, suggesting a potential upside of 60.50%. Envista has a consensus price target of $28.54, suggesting a potential upside of 8.81%. Given BellRing Brands' stronger consensus rating and higher possible upside, equities research analysts plainly believe BellRing Brands is more favorable than Envista.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
BellRing Brands	1 Sell rating(s)	9 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.47
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

95.0% of BellRing Brands shares are owned by institutional investors. 1.5% of BellRing Brands shares are owned by insiders. Comparatively, 1.0% of Envista shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

BellRing Brands beats Envista on 11 of the 17 factors compared between the two stocks.

How does Envista compare to Zimmer Biomet?

Envista (NYSE:NVST) and Zimmer Biomet (NYSE:ZBH) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, institutional ownership, media sentiment and valuation.

88.9% of Zimmer Biomet shares are owned by institutional investors. 1.0% of Envista shares are owned by insiders. Comparatively, 1.3% of Zimmer Biomet shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Envista presently has a consensus target price of $28.54, suggesting a potential upside of 8.81%. Zimmer Biomet has a consensus target price of $102.33, suggesting a potential upside of 8.76%. Given Envista's stronger consensus rating and higher possible upside, equities research analysts plainly believe Envista is more favorable than Zimmer Biomet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Zimmer Biomet	3 Sell rating(s)	13 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.25

In the previous week, Zimmer Biomet had 5 more articles in the media than Envista. MarketBeat recorded 11 mentions for Zimmer Biomet and 6 mentions for Envista. Zimmer Biomet's average media sentiment score of 1.16 beat Envista's score of 0.65 indicating that Zimmer Biomet is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Zimmer Biomet	5 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Envista has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Zimmer Biomet has a beta of 0.46, meaning that its share price is 54% less volatile than the broader market.

Zimmer Biomet has higher revenue and earnings than Envista. Zimmer Biomet is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envista	$2.72B	1.57	$47M	$0.41	63.97
Zimmer Biomet	$8.23B	2.21	$705.20M	$3.85	24.44

Zimmer Biomet has a net margin of 9.05% compared to Envista's net margin of 2.41%. Zimmer Biomet's return on equity of 13.24% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envista	2.41%	7.11%	3.91%
Zimmer Biomet	9.05%	13.24%	7.28%

Summary

Zimmer Biomet beats Envista on 13 of the 17 factors compared between the two stocks.

How does Envista compare to Solventum?

Solventum (NYSE:SOLV) and Envista (NYSE:NVST) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

Solventum has higher revenue and earnings than Envista. Solventum is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Solventum	$8.33B	1.61	$1.56B	$8.16	9.50
Envista	$2.72B	1.57	$47M	$0.41	63.97

In the previous week, Solventum had 3 more articles in the media than Envista. MarketBeat recorded 9 mentions for Solventum and 6 mentions for Envista. Solventum's average media sentiment score of 1.32 beat Envista's score of 0.65 indicating that Solventum is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Solventum	5 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Envista	1 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Solventum has a beta of 0.66, meaning that its stock price is 34% less volatile than the broader market. Comparatively, Envista has a beta of 0.86, meaning that its stock price is 14% less volatile than the broader market.

Solventum currently has a consensus price target of $83.67, suggesting a potential upside of 7.98%. Envista has a consensus price target of $28.54, suggesting a potential upside of 8.81%. Given Envista's higher probable upside, analysts clearly believe Envista is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Solventum	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43
Envista	0 Sell rating(s)	10 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Solventum has a net margin of 17.33% compared to Envista's net margin of 2.41%. Solventum's return on equity of 23.51% beat Envista's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Solventum	17.33%	23.51%	7.63%
Envista	2.41%	7.11%	3.91%

Summary

Solventum beats Envista on 11 of the 14 factors compared between the two stocks.

Get Envista News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NVST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NVST vs. The Competition

Export

Metric	Envista	MED PRODUCTS Industry	Medical Sector	NYSE Exchange
Market Cap	$4.22B	$8.82B	$7.05B	$23.46B
Dividend Yield	N/A	2.54%	2.68%	4.02%
P/E Ratio	63.97	16.09	27.11	31.08
Price / Sales	1.57	7.04	587.92	19.77
Price / Cash	11.93	18.40	29.22	18.64
Price / Book	1.39	3.57	10.75	4.77
Net Income	$47M	$228.19M	$3.58B	$1.06B
7 Day Performance	-3.44%	-2.31%	-2.06%	-0.23%
1 Month Performance	6.86%	-0.62%	3.32%	-0.11%
1 Year Performance	30.85%	-2.73%	26.36%	16.46%

Envista Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NVST Envista	2.4326 of 5 stars	$26.23 +1.2%	$28.54 +8.8%	+29.9%	$4.22B	$2.72B	63.97	12,000
ALGN Align Technology	3.753 of 5 stars	$188.39 +2.1%	$205.85 +9.3%	-10.7%	$13.21B	$4.03B	31.61	20,290
XRAY DENTSPLY SIRONA	4.0289 of 5 stars	$12.32 +5.8%	$13.55 +9.9%	-21.2%	$2.33B	$3.68B	N/A	14,000
BRBR BellRing Brands	4.1649 of 5 stars	$13.44 -3.0%	$22.47 +67.2%	-78.0%	$1.61B	$2.32B	10.42	380
ZBH Zimmer Biomet	3.5342 of 5 stars	$89.75 +2.6%	$102.70 +14.4%	+0.2%	$16.92B	$8.23B	23.31	17,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:NVST) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

How does Envista compare to Align Technology?

Summary

How does Envista compare to DENTSPLY SIRONA?

Summary

How does Envista compare to BellRing Brands?

Summary

How does Envista compare to Zimmer Biomet?

Summary

How does Envista compare to Solventum?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envista (NVST) Competitors

NVST vs. ALGN, XRAY, BRBR, ZBH, and SOLV

How does Envista compare to Align Technology?

Do insiders & institutionals hold more shares of ALGN or NVST?

Which has more volatility & risk, ALGN or NVST?

Is ALGN or NVST more profitable?

Which has higher valuation and earnings, ALGN or NVST?

Do analysts prefer ALGN or NVST?

Does the media prefer ALGN or NVST?

Summary

How does Envista compare to DENTSPLY SIRONA?

Which has stronger valuation & earnings, XRAY or NVST?

Do institutionals & insiders believe in XRAY or NVST?

Does the media prefer XRAY or NVST?

Is XRAY or NVST more profitable?

Do analysts prefer XRAY or NVST?

Which has more risk & volatility, XRAY or NVST?

Summary

How does Envista compare to BellRing Brands?

Is BRBR or NVST more profitable?

Which has better earnings & valuation, BRBR or NVST?

Does the media prefer BRBR or NVST?

Which has more volatility and risk, BRBR or NVST?

Do analysts recommend BRBR or NVST?

Do institutionals and insiders hold more shares of BRBR or NVST?

Summary

How does Envista compare to Zimmer Biomet?

Do institutionals & insiders hold more shares of NVST or ZBH?

Do analysts prefer NVST or ZBH?

Does the media refer more to NVST or ZBH?

Which has more volatility and risk, NVST or ZBH?

Which has better valuation and earnings, NVST or ZBH?

Is NVST or ZBH more profitable?

Summary

How does Envista compare to Solventum?

Which has higher earnings & valuation, SOLV or NVST?

Does the media favor SOLV or NVST?

Which has more risk & volatility, SOLV or NVST?

Do analysts rate SOLV or NVST?

Is SOLV or NVST more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

NVST vs. The Competition

Envista Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools